How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Pharma Industry News Novartis to acquire Cadent Therapeutics in $770m deal to bolster neuropsychiatric pipeline Find out how Novartis plans to transform neuroscience with its $770M acquisition of Cadent Therapeutics and its novel CNS treatment pipeline. bypharmanewsdailyDecember 19, 2020
